MarketInOut Stock Screener Log In | Sign Up
 

Orion Oyj Series B

HEL • Healthcare • Drug Manufacturers - General • Quote as of 08/07/2026
Orion Oyj Series B stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHEL
Market Capitalization11,262 mln
Float123 mln
Earnings Date10/28/2026

EPS

4.18
Solid

P / E

19.55
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.41
Manipulation likely

1-Year Forecast

76.67
Limited downside

Relative Strength

69 / 100
Outperforming

Business Description

Founded in Finland in 1917, Orion Oyj is a pharmaceutical company that creates and sells a wide range of medicines for both people and animals across Europe, North America, and beyond. Its human health portfolio covers treatments for conditions such as prostate cancer, Parkinson's disease, heart failure, asthma, and several other serious illnesses, while its animal health range serves veterinary needs worldwide. The company also produces active pharmaceutical ingredients, offers contract manufacturing, and sells self-care products including vitamins, supplements, and skincare items. Orion works alongside partners such as Bayer and Tenax Therapeutics to develop new treatments, and its products are available through both traditional and online channels.

Key Fundamentals

EPS4.18
P/E19.55
ROE48.91
RPS13.88
ROIC35.43
ROA28.82
Interest Cover155
EBITDA, mln668
EV / EBITDA16.32
EV / EBIT16.32
Revenue, mln1,953
EV / Revenue5.59

Financial Strength

Altman Z-Score9.88
Piotroski F-Score 6 / 9
Beneish M-Score-1.41
Price to Intrinsic Value2.97
Price to Lynch Fair Value1.26
Price to Graham Number3.35
1-Year Target Price76.67
Shiller PE Ratio35.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.49% 43 / 100   
1 Month 15.52% 89 / 100   
2 Months 18.63% 83 / 100   
6 Months 13.86% 85 / 100   
1 Year 17.1% 73 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us